Drugs / HER-2/neu peptide vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01729884 | Dec 2012 → Jun 2013 | HER2 positive breast carcinoma, male breast carcinoma | University of Washington | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HER-2/neu peptide vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01729884 ↗ |
| Modality | Vaccine | “HER-2/neu peptide vaccine” NCT01729884 ↗ |